GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (XCNQ:BLAB) » Definitions » Equity-to-Asset

Britannia Life Sciences (XCNQ:BLAB) Equity-to-Asset : 0.35 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Britannia Life Sciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Britannia Life Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$7.91 Mil. Britannia Life Sciences's Total Assets for the quarter that ended in Dec. 2023 was C$22.96 Mil. Therefore, Britannia Life Sciences's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.35.

The historical rank and industry rank for Britannia Life Sciences's Equity-to-Asset or its related term are showing as below:

XCNQ:BLAB' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.05   Med: 0.25   Max: 0.35
Current: 0.35

During the past 3 years, the highest Equity to Asset Ratio of Britannia Life Sciences was 0.35. The lowest was -0.05. And the median was 0.25.

XCNQ:BLAB's Equity-to-Asset is ranked worse than
73.32% of 1567 companies
in the Biotechnology industry
Industry Median: 0.66 vs XCNQ:BLAB: 0.35

Britannia Life Sciences Equity-to-Asset Historical Data

The historical data trend for Britannia Life Sciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences Equity-to-Asset Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23
Equity-to-Asset
-0.01 0.06 0.30

Britannia Life Sciences Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.30 0.31 0.33 0.35

Competitive Comparison of Britannia Life Sciences's Equity-to-Asset

For the Biotechnology subindustry, Britannia Life Sciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Britannia Life Sciences's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Britannia Life Sciences's Equity-to-Asset falls into.



Britannia Life Sciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Britannia Life Sciences's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=7.023/23.548
=0.30

Britannia Life Sciences's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=7.914/22.964
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Britannia Life Sciences  (XCNQ:BLAB) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Britannia Life Sciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Britannia Life Sciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Britannia Life Sciences (XCNQ:BLAB) Business Description

Traded in Other Exchanges
N/A
Address
120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc is a diversified product development, quality assurance, and safety & regulatory compliance company supporting clients in the CPG, cosmetics, household goods, and nutraceutical industries in the United Kingdom.

Britannia Life Sciences (XCNQ:BLAB) Headlines

No Headlines